Kraig Biocraft Laboratories Inc (KBLB)

[SilkRoad]

Why uplist to NASDAQ doesn’t matter and why it does.

1. Uplist to NASDAQ doesn’t matter because silk production in metric quantities is what is needed to take this company to the next level and make $$$. Companies like Roche, BASF, and Walmart de Mexico are listed on OTC. Uplisting to NASDAQ won’t do anything to increase silk production. Uplisting will not increase sales revenue either. Uplisting will require the company to meet requirements it does not have to meet now.

2. Uplist to NASDAQ does matter because many brokerage houses where clients have real brokers will not allow their clients to trade in penny stocks. The main reason is that penny stocks are seen as highly volatile and the brokerage firms will not follow or provide research to their clients on penny stocks. KBLB would best wait to either establish metric ton production and sales revenue or organically grow the pps before uplisting to NASDAQ. Uplisting to a major stock exchange has been a goal of the company’s founder and CEO.

So what do you think? Is uplisting to NASDAQ right now good or bad for the company, for investors?